Detalhe da pesquisa
1.
Treatment patterns for patients initiating novel acute migraine specific medications (nAMSMs) in the context of monoclonal antibodies (mAbs) targeting the calcitonin gene-related peptide (CGRP) pathway.
J Headache Pain
; 24(1): 153, 2023 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37946113
2.
Galcanezumab for the prevention of migraine.
Pain Manag
; 11(2): 101-112, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33291980